EpiBiologics is building a next-generation protein degradation platform that targets membrane and extracellular proteins. EpiBiologics was founded in 2022 based on the pioneering work from academic founder Dr. Jim Wells of the University of California San Francisco (UCSF). The Company’s proprietary EpiTAC platform is a modular antibody-based system that enables the precise degradation of disease-driving membrane and extracellular proteins in a tissue-specific manner. Headquartered in San Mateo, EpiBiologics is backed by leading healthcare investors and aims to develop first-in-class and best-in-class targeted therapies across multiple therapeutic areas. For more information, please visit epibiologics.com and follow us on LinkedIn.
Company Details
- Employees
- 41
- Address
- 1900 Alameda De Las Pulgas, San Mateo,california 94402,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.epibiologics.com/
- Keywords
- 62.
- HQ
- San Mateo, California
Epibiologics Questions
Epibiologics's website is https://www.epibiologics.com/
Epibiologics's LinkedIn profile is https://www.linkedin.com/company/epibiologics-inc
Epibiologics has
41 employees.
View email and phone details for 41
employees at Epibiologics.
Epibiologics's industry is
Biotechnology Research
Epibiologics's top competitors are
Xaira Therapeutics,
Altos Labs,
Natera,
Bighat Biosciences,
Denali Therapeutics,
Eikon Therapeutics,
Vir Biotechnology, Inc.,
Soteria Biotherapeutics,
Arsenal Biosciences, Inc.,
Genentech.
Epibiologics's categories are Biotechnology Research
